Leave a comment
Tag
Rob KowalskiChief People & Organization OfficerNovartis As Chief People & Organization (P&O) Officer of Novartis, Rob Kowalski leads the company’s strategy to unleash the power of its people and ensure it has the diverse talent, skills and organizational capabilities to deliver on its long-term priorities and purpose as a focused medicines company. Rob is passionate about fostering an Inspired, Curious and Unbossed culture that drives innovation and performance, and ultimately impacts how Novartis reimagines medicine for patients. Since taking his current position in 2021, he has played an instrumental role in implementing a new structure and operating model designed to…
Continue reading
— Robert ZamboldiSite Head – US Cell & Gene Therapy, Morris PlainsNovartis Rob Zamboldi is the Site Head and General Manager of Novartis’ flagship cell processing operation in Morris Plains, NJ providing worldwide supply of novel CAR-T therapies. Rob was instrumental in the ramp up of the first to market CAR-T, Kymriah ® of which more than 7,000 treatments have been supplied from his facility. Under Rob’s leadership, he oversaw the turnaround from a single product site into a multi-product manufacturing facility, delivering Novartis’ commercial and clinical products as well as securing multiple third-party contracts as a CMO provider. Rob’s…
Continue reading
As Novartis begins its journey to become a focused innovative medicines company, the Operations organization is evolving to make this ambition into a reality. A few years ago, we undertook a systematic approach of improving and optimizing our manufacturing capabilities. We brought in best practices, methodologies and tools to streamline processes, eliminate waste, reduce costs, improve quality and efficiency. We recognize that we have embarked on a continuous journey and we are happy to share how far we have come on: Operational Excellence: Embedding operational excellence to improve productivity and deliver high-quality medicines Innovation: Expanding platform capabilities in RNA,…
Continue reading
Beyond the buzzwords: Sharing lessons learned from a multi-year, global, culture transformation journey Discussing the role of upper management in shifting the culture of an organization Exploring the role of HR and evolution of HR practices to impact organizational culture — Fenella Chisholm SVP, Global People & Organization Novartis Fenella Chisholm is SVP and Global Head People & Organization for the Novartis Institutes for BioMedical Research (NIBR). In this role, Fenella partners with leadership across the 6000 strong global early discovery science unit to operationalize the Novartis People strategy in service of the vision to Reimagine Medicine and deliver better…
Continue reading
Investing capital in capacity expansion when a drug is early in development is challenging. There are new manufacturing models that reduce risk and add value to your decisions through a concept called optionality Balancing options and critically evaluated risk against probability of success in to-build decisions Introducing a new biomanufacturing solution that leverages manufacturing ecosystems to reduce the need to build infrastructure Effectively transfer non-value added work from the manufacturing site to service providers with this new manufacturing model — Daniel Palmacci has nearly 20 years of leadership experience in Biologics in the area of manufacturing, technical development, supply chain,…
Continue reading
